Infectious Diseases



Infectious Diseases





OVERVIEW AND ASSESSMENT

An infection results when a microorganism or pathogen colonizes a host organism, using its resources to live and replicate. A disease results when there is a change or impairment of normal tissue function due to the pathogen. An infectious disease differs from other types of disease, in that it is transmissible from the host to other individuals either horizontally or vertically from mother to baby.

Public health experts agree and literature supports that infection prevention can positively impact patient outcomes. Being a primary advocate of patient safety, nurses have a significant responsibility to learn about and ensure that the tenets of infection prevention are part of practice and being upheld at the bedside as well as in the community.


The Infectious Disease Process

The chain of infection includes six components that must be in succession for any infectious disease to evolve. If one link is eliminated from the chain, then transmission of the pathogen will not occur. Infection-control strategies are based on breaking the chain of infection. The six components of the chain of infection are pathogenic microorganism, reservoir, portal of exit from reservoir, mode of transmission, portal of entry into host, and susceptible host (Figure 31-1).


Pathogenic Microorganism

Must be able to enter the body and invade or colonize host tissue by attaching to specific host cells then cause damage to those cells by production of toxins or destructive enzymes. The pathogen may enter the body through any body orifice or broken skin. There are five types of infectious agents.


Types

Bacteria, viruses, fungi, parasites (protozoa, helminths), prions.



Reservoir

The environment in which a pathogenic microorganism lives and survives naturally; can be human, animal, or environmental. Examples of each type include:



  • Human—pulmonary tuberculosis.


  • Animal—ticks infected with the bacteria Borrelia burgdorferi, which causes Lyme disease.


  • Environment—Legionnaire’s disease (Legionella pneumonphila) through water.


  • Fomite— Methicillin (oxacillin)-resistant Staphylococcus aureus bacteria on a bedside table.


Portal of Exit from Reservoir/Portal of Entry into the Host

The portal of entry into the host is typically the same as the portal of exit from the reservoir.



  • Respiratory tract.


  • GI/GU tract.


  • Body fluids (except for sweat) such as blood, urine, semen.


  • Skin, mucous membranes.


  • Transplacental.







Figure 31-1. Chain of infection.


Mode of Transmission

How the pathogenic microorganism is spread to a host by an infectious source. Horizontal transmission is the spread of a pathogen from one individual to another individual or vertically from mother to offspring via transplacental transmission, contact through the birth canal, or through breastfeeding or close contact after birth. There are two main types of transmission: direct and indirect.








Table 31-1 Multidrug-Resistant Organisms (MDROs)























ORGANISM


OVERVIEW AND TRANSMISSION


PREVENTION (ALL)


Methicillin-resistant Staphylococcus aureus (MRSA)


Found in various body sites but especially in nares and on skin. Can produce toxins and invade body tissues. Transmitted via direct and indirect contact. Drug of choice: vancomycin.




  • Hand hygiene with soap or alcohol-based hand sanitizer.



  • Use of gloves and gowns for patient contact.



  • Isolate patient in private room or cohort patients with the same organisms on contact isolation.



  • Use disposable equipment or disinfect reusable items after removal from room.



  • Utilize a system for prompt identification and isolation of patients upon readmission and for discharge planning.



  • Health care worker, patient and family education.


Vancomycin-resistant enterococci (VRE)


Found in GI tract and female GU tract. Relatively weak pathogen, but if infection occurs treatment options are limited. Transmitted via direct and indirect contact.


Vancomycin intermediate- or vancomycin resistant-Staphylococcus aureus (VISA/VRSA)


Transmitted via direct and indirect contact. An epidemiologically significant organism that must be reported to the Centers for Disease Control and Prevention (CDC) and the local health department. Strictly follow contact precautions and dedicate staff for one-to-one care.


Multidrug-resistant Gram-negative rods such as Escherichia coli, Klebsiella pneumoniae, Acinetobacter species, and Pseudomonas aeruginosa


Found in various body sites, especially sputum. Spread via direct and indirect contact.


Emerging MDROs




  • Extended-spectrum metallo-beta lactamase (ESBLs) producers



  • Carbapenem-resistant enterobacteriaceae (CRE)




    • New Delhi metallo-b lactamase (NDM-1)


Produced by some Gram-negative bacteria, making them resistant to multiple antibiotics. Spread via direct and indirect contact. Limited treatment options due to resistance. Of concern worldwide.



Direct Transmission



  • Direct contact—infected by touching the reservoir (eg, Clostridium difficile fecal-to-oral transmission or rubella virus crossing the placenta to the fetus).


  • Droplet transmission.



    • Droplets of large particles more than 5 microns in size usually from respiratory secretions.


    • Transmitted through coughing, sneezing, or talking to an infected person (eg, human metapneumovirus spread through coughing).


    • Transmitted through aerosolizing procedures (eg, sprays of infectious agents during a nebulization treatment or a sputum induction).


  • Airborne transmission.



    • Droplet nuclei—less than 5 microns that remains suspended in air (eg, tuberculosis and varicella [primary chickenpox]).


    • Dust particles in the air containing the infectious agent (eg, Aspergillus fungi through dust).


Indirect Transmission

Touching an inanimate object or fomite that has had direct contact with the reservoir (eg, touching a tissue of a child with Influenza virus or touching a bedside table contaminated with Clostridium difficile).




  • Common vehicle route (through contaminated items).



    • Food (eg, Salmonella and Campylobacter).


    • Water (eg, cholera and Legionellosis).


    • Medications (eg, hepatitis C infection from contaminated multidose vials).


  • Vectorborne transmission.



    • A living creature acts as an intermediary acquiring a pathogen from one living host and transmits the disease agent to another living organism, often an arthropod (fly, mosquito, tick).


    • Can be mechanical (carried on the surface) or biological (host is infected with pathogen) vectors.


Susceptible Host



  • Determined by a complex interrelationship between a host and an infectious agent, by factors that influence infection or disease, such as:



    • Pathogenicity—the ability to produce disease in a host. The organism invades a host, enters tissue, colonizes then spreads from host to host while not necessarily causing death to the host;


    • Virulence—the wide range of damage that can occur to the host because of the toxic capabilities of the pathogen. Given that the host-pathogen relationship is fluid, the outcome can be dictated by:



      • Number of pathogens to which the host is exposed; route and duration of exposure.


      • Invasiveness of the pathogen and its ability to produce toxins.


      • Age, genetic constitution of host, and general physical, mental, and emotional health and nutritional status of host.


      • Ability to bypass or overcome host defense mechanisms (immunologic response).


Collection of Specimens


Proper collection and transport of specimens is important to maximize the outcome of laboratory tests for the diagnosis of infectious diseases. A variety of laboratory tests can be performed to make a presumptive or definitive diagnosis so that therapy can begin. See Standards of Care Guidelines 31-1.


Principles



  • It is imperative that specimens be collected and handled carefully if the causative agent for infection is to be identified correctly.


  • Specimens should be collected during the acute phase of infection and before the initiation of antibiotic therapy, if possible.


  • Obtain an adequate amount of the specimen necessary for all tests.


  • Avoid potential contamination of the specimen by using proper collection technique.


  • Check local laboratory guidelines for the specimen collection recommendations for each test. These guidelines should include the appropriate specimen containers, sample size, as well as transport requirements (temperature, time, etc.).


  • Label the container properly according to local laboratory protocol; in general, include the patient’s name, date of birth, medical record number, the source of the specimen, date and time collected, test to be performed, and any special instructions the provider may request.



  • Transport the specimen to the laboratory as soon as possible according to laboratory guidelines.


  • Be familiar with hospital policy recommending the transport of specified pathogens by staff personnel to the laboratory instead of via a pneumatic tube system.



Types of Specimen Collection


Blood Culture



  • Normally a sterile body fluid.


  • Specimens obtained by peripheral venipuncture are preferred over sampling from vascular catheters due to contamination of the catheter. Culturing hardware to determine a central line infection is not recommended in the literature.


  • Aseptic technique is essential to avoid contaminating the specimen with organisms colonizing the skin or the collector’s hands.


  • Cleanse the venipuncture site with 70% alcohol followed by chlorhexidine gluconate and allow to fully dry.


  • The diaphragm tops of the culture bottles are not sterile and must be cleaned with alcohol before injection of blood.


Urine Culture



  • Normally a sterile body fluid.


  • A clean-catch, midstream urine collection provides the best method for obtaining a specimen to detect a urinary tract infection (see page 774).


  • Patients who are catheterized should have the specimen withdrawn using a sterile syringe from the catheter sampling port (see page 781).


  • Urine specimens must be transported to the laboratory promptly. If not cultured within 30 minutes of collection, urine must be refrigerated and cultured within 24 hours.


  • Other types of urine specimens may be collected, such as a straight in-and-out catheter specimen (see page 778) or suprapubic bladder drainage (see page 784).


Stool Culture



  • Obtained to culture organisms that are not part of the normal bowel flora (eg, Salmonella species, Shigella species).


  • Patient should defecate into a sterilized container or bedpan. Stool specimens should not contain urine or water from the toilet bowl.


  • Stool specimens can also be obtained directly from the rectum using a sterile swab.


Sputum Culture



  • Specimen needs to be from the lower respiratory tract, not oropharyngeal secretions. The laboratory will perform a Gram stain on all sputum specimens to determine if they are representative of pulmonary secretions and appropriately collected. A specimen containing a majority of cells from squamous epithelium may be rejected.


  • The most common method of collection is expectoration from a cooperative patient with a productive cough. Early morning is the optimal time to collect sputum specimens.


  • A sputum specimen can be collected in a sputum trap from patients who have artificial airways and require suctioning.


  • If a patient cannot produce sputum, sputum induction using an aerosol nebulizer may assist with loosening thickened secretions.


  • Bronchoscopy may be required to obtain sputum if induction fails.


Wound Culture



  • Specimens are usually cultured for aerobic and anaerobic organisms.


  • Specimens may be collected by multiple techniques, depending on the depth of the wound, including tissue samples, needle aspiration, and swabbing the surface.


  • To collect a wound culture using a sterile swab, cleanse the surface and collect as much exudate as possible from the advancing margin of the lesion. Avoid swabbing surrounding skin.


  • Place the swab immediately in appropriate transport culture tube and send to the laboratory.


  • Label with the specific anatomic site.


Throat Culture



  • Use a tongue depressor to hold the tongue down.


  • Carefully yet firmly rub swab over areas of exudate or over the tonsils and posterior pharynx, avoiding the cheeks, teeth, and gums.


  • Insert swab into packet and follow directions for handling the transport medium.


Laboratory Tests


Microbiologic Evaluation


Microscopy



  • Microscopic examination distinguishes tissue cells from microorganisms.


  • Various stains are used to highlight the structural characteristics of microorganisms (eg, Gram stain, acid-fast stains to isolate mycobacteria).


  • Classification is conducted according to physical appearance such as shape, size, or tendency to form chains or clusters and stain reactions such as Gram-positive versus Gram-negative.


  • Results of microscopy are usually available within minutes, which permits early initiation of treatment based on a presumptive diagnosis.



Antibiotic Susceptibility Testing



  • Used to determine minimal concentration of antibiotics that will inhibit growth of an organism.



    • Minimum inhibitory concentration is the lowest concentration of an antimicrobial drug that will inhibit organism growth and is measured by the size of the zone around the antimicrobial disk in which growth is inhibited.


    • Based on Clinical and Laboratory Standards Institute guidelines for each organism, the size of the inhibitory zone diffusion tests are interpreted as resistant (R), sensitive (S), and intermediate (I).


Molecular Testing



  • There are technologies to detect specific genetic portions of pathogenic organisms or to identify the specific host’s response to the presence of the pathogen. Examples include DNA probe testing and polymerase chain reaction.


  • These tests often yield a more rapid result than culture.


White Blood Cell Count



  • An increase in white blood cell count or “leukocytosis” may indicate infection, inflammatory response, tissue necrosis, or bone marrow failure.


  • The total number of circulating leukocytes and the differential (given as a percent of the total white blood cell [WBC] count) may change during a bacterial or viral infection.


  • During an acute bacterial infection, the WBC count often increases (greater than 11,000/mm3), accompanied by increased neutrophils and increased bands (immature neutrophils) in the differential. The shift (to the left) in differential reflects phagocytic activity.


Immunologic Tests



  • Pathogens that are antigenic stimulate antibodies that can be detected in the serum of patients.


  • Detection of antibodies is not necessarily diagnostic of current infection.


  • Antigen-antibody reactions must be evaluated over a period of time.


  • Immunoglobulin M (IgM) antibody production peaks during active infection and decreases during convalescence.


  • IgG antibodies peak during convalescence and persist.


  • A fourfold rise in antibody titer between the acute and convalescence samples indicates recent infection.


GENERAL PROCEDURES AND TREATMENT MODALITIES


Immunity

The human body is equipped with defense mechanisms to ward off disease. These include anatomical barriers, such as the skin, and physiological barriers, such as enzymes in saliva. The normal flora of microorganisms on and in the body also helps to prevent invasion of pathogens. If these nonspecific defense mechanisms fail, the body’s specific immune response usually provides protection. Specific immunity to a particular organism implies that an individual has either generated the appropriate antibody in his or her own body or received ready-made antibodies from another source. Immunity may be natural or acquired or passive or active.

Natural active immunity occurs when antibodies are acquired following an infection. Antibodies are also acquired through natural passive immunity, such as from mother to fetus through the placenta or to infant via breast milk.

Passive artificial immunity is achieved through administration of immune globulin or antitoxin. Active artificial immunity occurs when antibodies are produced in response to a vaccine or toxoid (see Table 31-2).


Infection Prevention

Health-care-associated infections (HAIs) occur when a patient comes to a health care facility and acquires a new infection during their care. HAIs affect 2 million patients a year (2002) and, conservatively, 99,000 of those people die annually as a result. An intensive-care patient has a 30% chance of acquiring an HAI. In the United States, the cost for these infections is $28 to $33 billion a year.

The four most common HAIs for which hospitals perform surveillance are (1) surgical site infection; (2) central line-associated bloodstream infection; (3) ventilator-associated pneumonia; and (4) catheter-associated urinary tract infection. HAI rates are increasingly being used as indicators of quality and patient safety in health care facilities. Hospitals are reporting infection rates to the National Health Safety Network, part of the Centers for Disease Control and Prevention (CDC), and the data is being published and made available to the public.

In addition to surveillance of select HAIs, other infection prevention efforts include monitoring transmission of multidrug-resistant organisms (MDROs), hospital-wide hand hygiene compliance, antimicrobial stewardship, cleaning and disinfection, occupational health including vaccine compliance, staff education, and performance improvement initiatives to reduce HAIs.

Control and prevention of disease transmission by use of isolation precautions has a long history in health care facilities. Currently in health care facilities, those at highest risk are burn patients, neonates, those with MDROs, those with invasive lines, and anyone in intensive care units.


Fundamentals of Standard Precautions

In 1996, the CDC issued an isolation guideline for hospitals. It synthesized the major features of Universal Precautions and Body
Substance Isolation into a single set of precautions, called standard precautions. Standard precautions apply to (1) blood; (2) all body fluids, secretions, and excretions (except sweat), regardless of whether or not they contain visible blood; (3) nonintact skin; and (4) mucous membranes. As a common practice, standard precautions are recommended for the care of all patients in any environment, every time. If there is a chance of coming into contact with a potentially infectious material, a barrier is recommended to be placed between the patient and the care provider. The barrier may be a gown, glove, mask, or goggles, depending on the reason and area of contact.








Table 31-2 Recommended Adult Immunization Schedule—United States, 2012





image



Hand Hygiene



  • Hand hygiene is the single most recommended measure to reduce the risks of transmitting microorganisms.


  • Hand hygiene should be performed between patient contacts; after contact with blood, body fluids, secretions, excretions, and contaminated equipment or articles; before donning and after removing gloves is vital for infection control. It may be necessary to clean hands between tasks on the same patient to prevent cross-contamination of different body sites.


  • To perform hand hygiene, clean hands with soap and water, applying friction for 15 seconds upon all surfaces of the hands, or applying alcohol-based waterless hand sanitizer covering all surfaces of both hands until completely dry.


  • Waterless hand cleaners are recommended unless there is visible soil on the hands, before eating, after using the restroom, and when there is significant buildup of waterless hand cleaners.


  • If caring for a patient with a spore-producing pathogen such as Clostridium difficile-associated disease (CDAD), then use hand hygiene with soap and water applying friction for 15 seconds, as the spores this organism forms are resistant to alcohol hand gel.


  • Similarly, for other pathogens known or suspected to be resistant to alcohol waterless hand gels—such as Norovirus— hand hygiene with soap and water while applying friction for 15 seconds.


Respiratory Hygiene/Cough Etiquette



  • When coughing or sneezing, cover the mouth and nose with a tissue or the fabric of your sleeve.



  • Use the nearest waste receptacle to dispose of the tissue after use.


  • Perform hand hygiene immediately.


  • Apply a mask when coughing or sneezing to contain secretions.


  • Sit at least 3 feet from others.


Transmission-Based Precautions

In addition to standard precautions, the CDC recommends instituting transmission-based precautions when there is a suspicion for, or a laboratory confirmed case involving, an epidemiologically significant pathogen. There are three types of transmission-based precautions recommended by the CDC being contact, droplet, and airborne. Each type of isolation takes into account the pathogen and its mode of transmission. Always refer to each health care facility’s infection control policies as hospitals have the option to be more restrictive than the CDC recommendations influenced by endemic or newly emerging pathogens in that region.



Contact Precautions

Jun 14, 2016 | Posted by in NURSING | Comments Off on Infectious Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access